Page Menu

Laura Alonso honored with election into the American Society for Clinical Investigation

Date Posted: Monday, April 08, 2019

 
Laura Alonso, MD, The George F. and Sybil H. Fuller Term Chair in Diabetes, Director of Beta Cell Biological Studies at the UMass Diabetes Center of Excellence, and Professor of Medicine at University of Massachusetts Medical School, has been elected to the American Society for Clinical Investigation (ASCI).  One of the nation’s oldest and most prestigious medical honor societies, ASCI supports the work of top physician-scientists whose biomedical research translates findings in the laboratory to the advancement of clinical practice. 

Dr. Alonso was selected among hundreds of physician-scientists nominated by their peers for outstanding achievement in biomedical research.  She was formally inducted at the ASCI’s annual meeting on April 5, 2019 in Chicago, joining more than 3,000 members representing a wide range of specialties.  Election to the ASCI represents early-career accomplishment, as researchers must be 50 years of age or younger to be eligible for nomination to the Society. 

The main focus of Alonso Lab is to understand which pathways guide beta cell proliferation, to find approaches to make more beta cells, to prevent or treat diabetes.  In addition, she's a practicing endocrinologist, treating people living with diabetes to help manage their disease and its complications. 

Dr. Alonso completed her medical degree at University of Pennsylvania School of Medicine, followed by residency in internal medicine and Fellowship training in Endocrinology at the University of Chicago Hospitals.  She also completed a Research Fellowship in Stem Cell Biology at The Rockefeller University.   

To learn more about the research currently taking place in the Alonso Lab, click here.

Additional Resources
click to open search panel